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Abstract
Aging is characterized by the accumulation of damaged cellular macromolecules caused by declining repair and elimination
pathways. An integral component employed by cells to counter toxic protein aggregates is the conserved ubiquitin/
proteasome system (UPS). Previous studies have described an age-dependent decline of proteasomal function and
increased longevity correlates with sustained proteasome capacity in centenarians and in naked mole rats, a long-lived
rodent. Proof for a direct impact of enhanced proteasome function on longevity, however, is still lacking. To determine the
importance of proteasome function in yeast aging, we established a method to modulate UPS capacity by manipulating
levels of the UPS–related transcription factor Rpn4. While cells lacking RPN4 exhibit a decreased non-adaptable proteasome
pool, loss of UBR2, an ubiquitin ligase that regulates Rpn4 turnover, results in elevated Rpn4 levels, which upregulates UPS
components. Increased UPS capacity significantly enhances replicative lifespan (RLS) and resistance to proteotoxic stress,
while reduced UPS capacity has opposing consequences. Despite tight transcriptional co-regulation of the UPS and
oxidative detoxification systems, the impact of proteasome capacity on lifespan is independent of the latter, since
elimination of Yap1, a key regulator of the oxidative stress response, does not affect lifespan extension of cells with higher
proteasome capacity. Moreover, since elevated proteasome capacity results in improved clearance of toxic huntingtin
fragments in a yeast model for neurodegenerative diseases, we speculate that the observed lifespan extension originates
from prolonged elimination of damaged proteins in old mother cells. Epistasis analyses indicate that proteasome-mediated
modulation of lifespan is at least partially distinct from dietary restriction, Tor1, and Sir2. These findings demonstrate that
UPS capacity determines yeast RLS by a mechanism that is distinct from known longevity pathways and raise the possibility
that interventions to promote enhanced proteasome function will have beneficial effects on longevity and age-related
disease in humans.
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Introduction
Oxidative and other forms of damage to cellular components
occur throughout the lifespan of organisms [1]. Young cells are
protected by efficient repair and elimination systems, while aging
cells gradually accumulate damaged macromolecules and organ-
elles leading eventually to a catastrophic functional deterioration
and cell death. Many reports document a gradual decline in repair
and maintenance systems in aging cells [2], suggesting that
impaired repair and clearance of damaged macromolecules
represents a crucial origin of age-related cellular dysfunction [3].
Ribosomes, chaperones and two proteolytic systems, the
proteasome and the autophagosomal/lysosomal pathway, are
responsible for the maintenance of protein homeostasis [4]. If
translation and chaperone-assisted protein folding/disaggregation
fail, larger protein aggregates or damaged organelles are cleared
by macroautophagy in all eukaryotes, while specific proteins are
removed from the cytoplasm by chaperone-mediated autophagy in
mammals [5]. Both activities result in destruction of damaged
molecules in an enclosed hydrolytic environment, the lysosome.
Damaged proteins in the nucleus and cytoplasm of eukaryotic cells
are eliminated by the ubiquitin/proteasome system [6].
PLoS Genetics | www.plosgenetics.org 1 September 2011 | Volume 7 | Issue 9 | e1002253The proteasome is a highly conserved, multicatalytic enzyme
composed of more than 33 subunits, which form two entities. The
central proteolytic core (CP) contains the proteolytically active sites
sequestered within an enclosed cylinder, while a regulatory
complex (RP) mediates substrate recognition, processing and
transport into the catalytic chamber of the CP [6]. Crucial
components of the RP are six paralogous ATPases. They actively
unfold bound proteins, a process that is required for the passage of
substrates through a narrow gate leading into the interior of the
CP [6,7]. Substrate binding by the proteasome requires covalent
modification of a target protein with a polyubiquitin chain, which
is attached to a substrate via a three-step enzymatic cascade
involving ubiquitin activation by E1 enzymes, ubiquitin conjuga-
tion by E2 proteins and covalent linkage of ubiquitin to substrates
by E3 ubiquitin ligases [6].
Many studies demonstrate a decline in proteasome function
with age in different organisms [8,9]. Proteasome impairment is
reported at several levels, including decreased transcription of
certain proteasomal subunits in mice [10], dissociation of the
holocomplex in Drosophila [11], and reduced proteolytic capacity in
different aged mammalian tissues and organs [12]. In contrast,
centenarians and the long-lived naked mole rats exhibit elevated
proteasome levels and activity [13,14]. Initial genetic approaches
suggest a role for proteasome function in modulating longevity. In
the fission yeast Saccharomyces pombe, the maintenance of a quiescent
G0 state is dependent on functional proteasomes [15], and
downregulation of proteasome RP subunits in C. elegans leads to a
profound shortening of lifespan [16]. Moreover, studies in
Saccharomyces cerevisiae and Drosophila indicate that overexpression
of proteasome-related genes might exert a positive effect on
lifespan. Elevated levels of the proteasome biogenesis factor Ump1
are reported to extend yeast stationary phase survival [17],
although replicative lifespan has not been investigated. Further-
more, overexpression of the proteasomal deubiquitinating subunit
Rpn11 extends lifespan in flies [18]. While enhanced proteasome
activity was speculated to be the cause of lifespan extension in both
studies, the underlying impact of UPS component overexpression
on proteasome biology was not fully elucidated. Studies in yeast
suggest a proteasome independent function of a free Rpn11 pool
in the maintenance of mitochondrial morphology, thus extended
lifespan in flies overexpressing Rpn11 might result from functions
of Rpn11 that are independent of the proteasome [19].
Here we present a genetically defined system utilizing
transcriptional regulation of the UPS to study the effect of
decreased and elevated proteasome capacity on yeast replicative
lifespan. Expression of UPS genes in yeast and mammals is
regulated by a feedback mechanism [20,21]. In the absence of
proteotoxic stress, the UPS-related transcription factor Rpn4 has a
short half-life of several minutes, being rapidly ubiquitinated by
the E3 ligase Ubr2 and degraded by the proteasome [22]. This
feedback loop ensures a fast and tightly regulated increase in
proteasome levels during protein stress; increased degradation of
proteasome substrates reduces turnover of Rpn4, promoting a
compensatory elevation of proteasomal gene transcription [20,21].
Cells deleted for RPN4 exhibit reduced basal non-adaptable
proteasome levels. In contrast, loss of the E3 ligase Ubr2 leads to
Rpn4 stabilization, which in turn results in elevated proteasome
abundance and increased UPS capacity [22]. Utilizing this system,
we found that proteasome abundance correlated with longevity.
Deletion of RPN4 shortened lifespan, while loss of UBR2
dramatically increased lifespan, demonstrating a beneficial effect
of elevated proteasome function on cell physiology. The same
correlation between reduced and elevated proteasome capacity is
evident from phenotype analysis in the presence of proteotoxic
stress. Increased turnover of structurally unstable proteins as well
as enhanced clearance of aggregation prone huntingtin fragments
was observed in cells with elevated proteasome function, whereas
loss of UBR2 failed to induce lifespan extension in cells with
compromised proteasome function. These findings argue for a
model in which the beneficial effect of increased proteasome
capacity on longevity is related to improved elimination of
damaged or aggregation prone proteins and thus improved
proteostasis, possibly representing a major function of the
proteasomes in aging cells.
Results
Reduced replicative lifespan in proteasome hypomorphic
mutants
To more broadly define the importance of proteasome function in
aging, we measured replicative lifespan (RLS) for several yeast
mutants that recapitulate the individual processes causing proteasome
dysfunction in mammalian aging and cell senescence: loss of activity,
impaired assembly/structural integrity and decreased abundance
[8,9]. The proteasomal ATPases Rpt1-6 are essential components of
the catalytic cycle of the proteasome. Mutants with inactivated ATP-
hydrolysis are viable but show impaired substrate turnover [23].
Consistent with the observed decline in proteolytic capacity of the
proteasome with aging in multicellular eukaryotes, ATPase mutants
in 5 of these 6 components exhibited reduced RLS (Figure 1A). The
varying degree in RLS reduction is in agreement with previous
findings that the ATPases play non-redundant roles in proteasome-
mediated substrate turnover [23]. Several further studies (Figure 1B)
emphasize the requirement of normal proteasome function for
normal lifespan. First, deletion of the proteasome biogenesis factor
UMP1, which is required for correct proteasome maturation [24],
leads to reduced RLS. Second, deletion of the only non-essential
integral proteasome core subunit PRE9, which results in impaired
proteasome assembly and impaired proteolytic capacity [25],
shortens RLS. Third, a ubp6D strain is also short-lived. Ubp6 is a
proteasome associated deubiquitinating enzyme, which influences
Author Summary
Theubiquitin/proteasomesystem(UPS)isanintegralpartof
the machinery that maintains cellular protein homeostasis
and represents the major pathway for specific protein
degradation in the cytoplasm and nuclei of eukaryotic cells.
Its proteolytic capacity declines with age. In parallel,
substrate load for the UPS increases in aging cells due to
accumulated protein damage. This imbalance is thought to
be an origin for the frequently observed accumulation of
protein aggregates in aged cells and is thought to
contribute to age-related cellular dysfunction. In this study,
we investigated the impact of proteasome capacity on
replicative lifespan in Saccharomyces cerevisiae using a
genetic system that allows manipulation of UPS abundance
at the transcriptional level. The results obtained reveal a
positive correlation between proteasome capacity and
longevity, with reduced lifespan in cells with low protea-
some abundance or activity and strong lifespan extension
upon up-regulation of the UPS in a mechanism that is at
least partially independent of known yeast longevity
modulating pathways. The same correlation is observed
for oxidative and protein stress tolerance and clearance of
toxic huntingtin fragments in a yeast model for neurode-
generative diseases, suggesting that lifespan extension by
increased proteasome capacity is caused by improved
protein homeostasis.
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impacts the turnover of proteasome substrates [26]. Lastly, cells
lacking the transcriptional regulator of proteasome expression, the
C2H2 zinc-finger transcription factor RPN4, which are characterized
by a reduced, non-adaptable proteasome pool [20,21], exhibit a 40%
reduction in mean RLS (Figure 1B). These results demonstrate that
defects in several different aspects of proteasome biology are sufficient
to shorten lifespan.
Figure 1. Replicative lifespan in cells with proteasome-related gene mutations or deletions. Mean lifespan and cell counts are shown in
parenthesis. (A) Proteasome ATPase mutants. Survival curves for cells with individually inactivated proteasomal ATPases (SUB62 strain background).
(B) Viable proteasome-related gene deletions. Survival curves for cells deleted for the proteasome maturation factor UMP1, the proteasome
associated deubiquitinating enzyme UBP6, the only non-essential CP subunit PRE9, and the proteasome-related transcription factor RPN4 (BY strain
background). (C) and (D) RLS lifespan extension in ubr2D (C) and mub1D (D) cells. Survival curves of cells deleted for RPN4, UBR2,o rRPN4 UBR2 (C) or
RPN4, MUB1,o rRPN4 MUB1 (D). (E) Deletion of TOM1 causes RLS extension independent of RPN4. Survival curves of cells deleted for RPN4, TOM1, or
RPN4 TOM1. (F) Lifespan extension induced by loss of UBR2 requires functional proteasomes. Survival curves of cells deleted for PRE9, UBR2, or PRE9
UBR2. A statistical analysis of the data is summarized in Table S2.
doi:10.1371/journal.pgen.1002253.g001
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Since reduction in proteasome function resulted in decreased
RLS, we reasoned that an increase in proteasome number might
enhance longevity. An ideal candidate to manipulate proteasome
levels is Rpn4, due to its specific function as a regulator of
proteasomal gene transcription [20,21]. We hypothesized that a
rise in Rpn4 protein levels would increase proteasome abundance
and might positively impact lifespan. Loss of either of two proteins
is known to result in elevated Rpn4 protein levels: the E3 ubiquitin
ligase Ubr2 [22], and Mub1, a protein required for Ubr2-
mediated Rpn4 ubiquitination [27]. To test whether elevated
Rpn4 levels enhance longevity, we determined the RLS of strains
lacking UBR2 or MUB1. Strikingly, both ubr2D and mub1D mother
cells were significantly longer-lived than wild type cells (Figure 1C,
1D). This effect was dependent on Rpn4, since deletion of RPN4
abrogated lifespan extension in ubr2D or mub1D strains (Figure 1C,
1D), arguing for a model in which the enhanced longevity of ubr2D
and mub1Dcells resulted from stabilization of Rpn4. Importantly,
RPN4 is not required for lifespan extension in a long-lived strain
lacking TOM1 (Figure 1E), another E3 ligase involved in
transcriptional regulation [28]. These observations demonstrate
that lifespan extension by Rpn4 stabilization is specific for UBR2
and MUB1. Rpn4 stabilization is necessary but not sufficient for a
positive effect on lifespan, since compromised proteasome
function, induced by loss of PRE9, prevents lifespan extension in
ubr2D cells (Figure 1F).
Consistent with increased Rpn4 abundance in cells lacking
UBR2 (Figure 2A) or MUB1 we observed increased transcription
of proteasomal genes, both for components of the RP (RPN11 and
RPT2) and the CP (PRE1 and PRE6) (Figure 2B). The increased
transcription of proteasomal genes resulted in elevated protein
levels of RP and CP subunits (Figure 2C). To verify that the
increased subunit production leads to increased abundance of
functional proteasome complexes, we visualized active proteasome
populations in unfractionated lysates (Figure 2D) and tested the
three distinct proteasomal peptidase activities with proteasome-
specific fluorogenic peptide substrates from lysates of ubr2D or
mub1Dcells (Figure 3A, Figure S2). Both assays showed increased
proteasome capacity upon Rpn4 stabilization. Growth of the
strains remained, however, largely unaffected (Figure 3B, Figure
S3). In contrast, loss of RPN4 showed the opposite characteristics
(Figure 2, Figure 3A) and resulted in reduced growth rate
(Figure 3B, Figure S3). In every case, a direct correlation between
proteasome capacity and lifespan was observed: cells with a
reduced proteasome pool (rpn4D, rpn4D ubr2D rpn4D mub1D)
exhibited shortened RLS (Figure 1B–1E), while cells with high
proteasome capacity (ubr2D or mub1D) showed increased median
and maximum RLS, up to 70% longer than wild type cells
(Figure 1C, 1D). This is comparable to the longest-lived single
gene deletion strains reported or identified from our nearly
complete screen of the yeast ORF deletion collection [29–31; data
not shown].
The oxidative stress response does not contribute to
lifespan extension in cells with elevated Rpn4 levels
Damage to biological macromolecules resulting from reactive
oxygen species is thought to represent a major cause for age-
related cellular dysfunction. Two strategies are employed by cells
to counteract oxidative damage: detoxification/repair and elim-
ination. In yeast, both strategies are controlled at the transcrip-
tional level via Rpn4, which regulates genes with PACE
(proteasome associated control elements) promoter elements
[32], and the AP-1 like leucine zipper transcription factor Yap1,
the major regulator of the oxidative detoxification response [33].
Yap1 promotes expression of genes with YRE (Yap1 response
elements) promoter elements. The regulation of both gene clusters
is linked through a positive feed back loop between Rpn4 and
Yap1. While Yap1 induces Rpn4 expression via an YRE element
in the promoter of RPN4, Yap1 expression is induced by Rpn4 via
a PACE element in the promoter of YAP1 [34]. This bistability
strategy most likely has evolved to ensure optimal response to
oxidative stress. In cells deleted for RPN4, this feed back loop
regulation causes reduced expression of Yap1 targets. Whether the
inverse scenario, an upregulation of genes required for detoxifi-
cation of reactive oxygen species (ROS), is observed upon
stabilization of RPN4 has not been investigated. Although lifespan
extension induced by Rpn4 stabilization requires functional
proteasomes (Figure 1F) a possible upregulation of Yap1 target
genes in ubr2D and mub1D strains might contribute to the increased
longevity exhibited by both strains.
To explore this possibility, we deleted YAP1 in ubr2D and mub1D
cells and examined their RLS. Loss of UBR2 or MUB1 (Figure 4A,
right panel) extended the lifespan of YAP1 deleted cells, providing
evidence that Yap1 induced detoxification of ROS does not
account for the increased longevity of cells with increased
proteasome capacity. This conclusion is corroborated by the lack
of induction of Yap1 target genes in ubr2Dand mub1D cells
(Figure 4B, middle and lower panels), despite upregulation of
YAP1 expression (Figure 4B, upper, right panel). The lack of Yap1
target gene induction is also apparent in a SILAC-based
quantitative proteome analysis of rpn4D and ubr2Dcells. While
the protein levels of proteasome subunits correlate with Rpn4
abundance (reduced abundance in rpn4D, increased abundance in
ubr2D cells) (Figure 5A, red labels), no correlation of proteins
required for oxidative detoxification is observed (Figure 5B, yellow
labels). The lack of increased Yap1 function despite elevated
transcription of the gene may reflect additional mechanisms for
controlling Yap1 activity, including proteasomal degradation [35]
and regulated differential localization [36].
In addition to co-regulation of the UPS and the oxidative stress
response, Rpn4 has been suggested to be involved in the induction
of genes required for base-excision repair after treatment of cells
with genotoxic agents [37,38]. Our proteome data set, however,
does not reveal a positive correlation between proteins involved in
DNA repair and Rpn4 abundance (Figure 5C), thus it appears
unlikely that upregulated DNA repair contributes to lifespan
extension in cells with elevated Rpn4 levels.
Improved proteotoxic stress response in cells with
elevated proteasome capacity
To characterize the effect of elevated proteasome activity on
protein homeostasis, we subjected the cells to several protein stress-
inducing conditions, which require correct proteasome function
for survival. Loss of UBR2 or MUB1 renders cells resistant to the
proteotoxic arginine analog canavanine (Figure 6A), to ER stress
as induced by tunicamycin (Figure 6B), and to the heavy metal
cadmium, which inhibits enzymes involved in detoxification of
reactive oxygen species (Figure 6C). In contrast, loss of RPN4
results in profound sensitivity to exogenous protein stress (Figure 6).
Importantly, RPN4 is required for the stress resistance of ubr2D or
mub1D cells, since a ubr2D rpn4D or a mub1D rpn4Dstrain is as
sensitive as rpn4D in each of the three conditions. In accord,
lifespan extension by ubr2D or mub1D is abrogated in a strain also
lacking RPN4 (Figure 1C, 1D). These findings indicate that Rpn4
stabilization, and thus elevated proteasome capacity, enhances the
cell’s ability to withstand proteotoxic stress and are consistent with
Elevated Proteasome Capacity Extends Lifespan
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PLoS Genetics | www.plosgenetics.org 5 September 2011 | Volume 7 | Issue 9 | e1002253the hypothesis that the increased lifespan of ubr2D or mub1D cells
results directly from improved protein homeostasis.
Improved elimination of unstable and aggregation prone
proteins in cells with increased proteasome capacity
To test whether cells with increased proteasome capacity
exhibit improved protein homeostasis, we investigated whether
ubr2D cells exhibit improved clearance of unstable and aggrega-
tion prone proteins in vivo. First, we determined the degradation
kinetics of a constitutively expressed unstable proteasome model
substrate (D2GFP) [39] in cells with increased or reduced
proteasome abundance after blocking new synthesis with lethal
doses of cycloheximide (CHX). Accelerated degradation of
D2GFP occurred in ubr2D cells, while RPN4 deleted cells
displayed reduced turnover (Figure 7A, 7B). The differential
turnover rates in cells with varying proteasome levels is further
reflected in the steady state level of D2GFP, as indicated by the
amount of the protein present at time 0 (Figure 7A). Secondly, we
tested a yeast model for age-associated neurodegenerative
disorders in which inducible CFP is fused to the first exon of
huntingtin with toxic (Htt103Q) or non-toxic (Htt25Q) glutamine
expansions [40,41]. These proteins were expressed in WT and
ubr2D cell, and the abundance and cellular distribution of
Huntingtin fragments were visualized by fluorescence in live
cells (Figure 8). Previously, these constructs have been shown to
form aggregates in yeast cells [40,41]. After 8 hours of induction
we did not observe a difference between WT (Figure 8A, left
panel) and ubr2D cells. After 14 hours, however, the level of
aggregates was strongly reduced in cells with elevated proteasome
capacity (Figure 8B, right panel) as compared to WT cells
(Figure 8A, right panel), suggesting improved clearance of the Htt
aggregates. The cellular distribution and the abundance of a non-
toxic huntingtin fragment, Htt25Q, remained unaffected by
increased proteasome capacity (Figure 8C).
Functional independence of proteasome-mediated
effects on lifespan
Previously, aging pathways have been linked to mitigation of
proteotoxic stress. For instance, dietary restriction and reduced
TOR signaling have been suggested to extend lifespan, at least in
part, through effects on mRNA translation and enhanced
autophagy in yeast, nematodes, and fruit flies [42]. Deletion of
TOR1, which codes for one of two partially redundant TOR
kinases, has been previously shown to extend RLS, and inhibition
of Tor1 is thought to mediate RLS extension from dietary
restriction [29]. Our findings indicate that deletion of TOR1
extends the lifespan of rpn4D mother cells (Figure 9A). Likewise,
dietary restriction by reducing the glucose concentration of the
medium also increased the lifespan of cells lacking RPN4
(Figure 9B). Deletion of GCN4, which has been previously shown
to be required for full lifespan extension in response to dietary
restriction or deletion of TOR1 [30], does not affect full lifespan
extension of ubr2D or mub1D cells (Figure 9C, 9D). These data
support the conclusion that the effect of the proteasome on
longevity pathways is at least partially distinct from dietary
restriction/TOR signaling. Finally, ubr2D cells retain the ability to
enhance longevity in a strain lacking both SIR2 and FOB1
(Figure 9E), indicating that increased Sir2 activity also does not
account for lifespan extension by elevated proteasome function.
These findings are consistent with the model that enhanced
proteasome activity increases RLS through a mechanism at least
partially distinct from the major known longevity pathways in
yeast.
Discussion
In this report we took advantage of the tight transcriptional
regulation of UPS components to increase the activity of the
ubiquitin/proteasome system. Through inhibiting the regulated
turnover of the proteasome-related transcription factor Rpn4 we
were able to increase proteasome abundance and activity ,1.5–2
fold. This strategy allowed us to investigate the effect of improved
proteasome capacity on yeast RLS. Our data demonstrate that
proteasome abundance and activity correlates with lifespan;
enhanced proteasome capacity dramatically increases longevity
in yeast, conferring an approximately 70% increase of medium
and maximum RLS. This is a robust effect, comparable to the
longest-lived single gene deletions identified and greater than the
extension observed either by deletion of TOR1 or overexpression
of SIR2 [29–31,43]. Given the high conservation of the
proteasome in all eukaryotes and a host of literature on the role
of declining proteasome function in aging cells and tissues in
different organisms [8–14], we speculate that increased protea-
some function might also positively affect aging in higher
eukaryotes. This hypothesis is supported by studies, which
revealed elevated proteasome capacity in long-lived organisms,
such as centenarians or naked mole rats [13,14].
Although the precise mechanism is yet to be elucidated, our
results suggest that improved protein quality control, and thus
protein homeostasis, might be the origin of extended lifespan in
cells with increased proteasome capacity. Cells with elevated
proteasome capacity retain rapid growth under protein stress
inducing conditions and are able to turnover structurally unstable
and aggregation-prone proteins at an enhanced rate. We cannot
rule out the possibility that increased proteasome capacity also
enhances turnover of negative regulators of lifespan in S. cerevisiae.
However, we have no evidence supporting this hypothesis.
Interestingly, the effect of the proteasome on lifespan appears to
be at least partially independent of known longevity-modulating
pathways in yeast, a phenomenon which might be explained by
the relatively autonomous regulatory mechanism for proteasome
level adaptation in response to proteotoxic stress, as described
above. Yet cross-communication between the proteasome and
Figure 2. Extended proteasome biogenesis and subunit abundance upon loss of UBR2 or MUB1. (A) Relative quantification of Rpn4
abundance in WT and ubr2D cells via SRM (selected reaction monitoring) (B) Expression of four proteasomal genes in cells deleted for RPN4, UBR2,
MUB1 or RPN4 UBR2 and RPN4 MUB1. The mRNA levels of two genes encoding proteasome CP subunits (PRE1 and PRE6) or RP subunits (RPN11 and
RPT2) were tested by qRT-PCR and presented relative to the housekeeping gene PRP8 as the mean +/2 SEM of three independent experiments.
P-values represent the statistical significance relative to WT gene expression. * = P-value of ,0.05 ** = P-value of ,0.01 *** = P-value of ,0.001. A
complete table of P-values can be found in Figure S1. (C) Elevated proteasome subunit levels in ubr2D and mub1D. Normalized lysates of the strains
indicated were subjected to SDS-PAGE and immuno-blotting with antibodies directed against CP (anti-CP and anti-a7) or RP subunits (anti-Rpn8 and
anti-Rpn5). The position of marker proteins is indicated to the left. (D) Unfractionated lysates of the strains indicated were subjected to native gel
electrophoresis followed by an in-gel activity assay with the fluorogenic proteasome-specific substrate Suc-LLVY-AMC. The fluorogenic signals shown
represent proteasome holocomplex activity. RP2-CP denotes proteasome core particles (CP) flanked on both sides with regulatory particles (RP),
Blm10-CP-RP a proteasome hybrid complex with the CP flanked on one side with the proteasome activator Blm10 and on the other side with RP, RP-
CP a singly RP capped CP.
doi:10.1371/journal.pgen.1002253.g002
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extension from TOR1 deletion was not achieved in cells with
reduced proteasome capacity. In this regard, it is worth noting that
transcription of RPN4 is controlled by HSF1, whose worm
counterpart is required for lifespan extension by dietary restriction
[44].
Similar to proteasome function, autophagy and the proteolytic
capacity of the lysosome declines with age in model organisms and
in mammals [45]. Many interventions, such as dietary restriction,
drug treatment, overexpression of sirtuins [46] or restoration of
autophagosomal function in old animals via transgenes in mice or
flies [47,48], result in increased autophagy and lifespan extension.
Figure 3. Elevated peptidase activity of proteasome holocomplexes in ubr2D and mub1D cells. (A) Elevated cellular proteasomal
peptidase activity in ubr2D and mub1D strains. The three distinct proteasomal peptidase activities of the strains indicated were tested with 50 mgo f
total protein in the presence of 100 mM of the fluorogenic substrates Suc-LLVY-AMC (chymotrypsin-like activity), Boc-RLR-AMC (trypsin-like activity)
and Ac-nLPnLD-AMC (caspase activity). The reactions were recorded in the absence or presence of 50 mg/ml of the proteasome inhibitor MG132
(Figure S2) to demonstrate specificity of the reactions. The mean +/2 SEM of three technical replicates is presented. (B) Growth is unaffected in cells
with increased proteasome abundance. Growth curves of WT, rpn4D, ubr2D, mub1D, rpn4D ubr2D and rpn4D mub1D strains were recorded in a
Bioscreen C MB machine in YPD at 30uC. Doubling times are listed in Figure S3.
doi:10.1371/journal.pgen.1002253.g003
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proteolytic systems appear to play important roles in determining
longevity. However, autophagy is also involved in apoptotic cell
death and may participate in limiting lifespan as suggested by
reports in C. elegans [49]. Thus, approaches to increase UPS
function in aging cells might represent viable alternative strategies
for modulating longevity and for future anti-aging drug develop-
ment.
Intriguingly, the autophagic and proteasomal systems also commu-
nicate [50]. Inhibition of the proteasome induces autophagy, and in
higher eukaryotes the lysosome is able to internalize ubiquitinated
proteins via specific ubiquitin receptors involved in autophagosome
formation [50]. Despite this, enhanced autophagy is clearly unable to
fully compensate for impaired proteasome function with respect to
yeast longevity, since we find that proteasome defects lead to short
l i f e s p a n .Am a j o rc h a l l e n g ef o rt h ef u t u r ew i l lb et od e t e r m i n et h e
Figure 4. Proteasome-mediated lifespan extension is independent of the oxidative stress response. (A) Survival curves of cells deleted
for UBR2, YAP1 or UBR2 YAP1 (left panel) or MUB1, YAP1,o rMUB1 YAP1 (right panel). Mean RLS and cell counts are shown in parenthesis. A statistical
analysis of the data is summarized in Table S2. (B) Expression of Rpn4 target genes PRE6 and YAP1 as well as four Yap1 target genes SOD2, TRR1, GRX2,
and TRX2 in cells deleted for RPN4, UBR2, or RPN4 UBR2. The mRNA levels were tested by qRT-PCR and presented relative to the housekeeping gene
PRP8 as the mean +/2 SEM of three independent experiments. P-values represent the statistical significance relative to WT gene expression.
*=P-value of ,0.05, ** = P-value of ,0.01, ns = not significant.
doi:10.1371/journal.pgen.1002253.g004
Elevated Proteasome Capacity Extends Lifespan
PLoS Genetics | www.plosgenetics.org 8 September 2011 | Volume 7 | Issue 9 | e1002253detailed mechanisms by which these proteolytic pathways modulate
longevity and what role they play during mammalian aging.
Materials and Methods
Strains and plasmids
The strains used in this study are listed in Table S1. All strains
are isogenic to BY4741 or BY4742 [51] and are S288C-derived,
except the strains used in Figure 1A. DY62, DY93, DY100,
DY106, DY155 and their parental strain SUB62 were kindly
provided by Daniel Finley. Complete genomic gene deletion was
achieved by homologous recombination using standard techniques
[52,53]. The plasmids pYES25Q-CFP and pYES103Q-CFP were
a kind gift of Michael Sherman and the plasmid pRP44 was kindly
provided by Davis Ng.
Figure 5. SILAC–based quantitative large-scale proteomics of cells with reduced and increased proteasome capacity. (A) SILAC ratios
for rpn4D/WT were plotted on the y-axis and SILAC ratios for ubr2D/WT were plotted on the x-axis. (A) Proteins transcribed from genes containing the
Rpn4 controlled PACE element were colored red. (B) Data points corresponding to proteins with the GO classification: oxidative stress (GO:0006979),
were colored orange. (C) SILAC ratios were plotted as described in (A). Data points corresponding to proteins with the GO classification: DNA repair
(GO:0006281) were colored orange. For all proteins and subselections Pearson correlation coefficients were calculated and R
2 values are presented.
Proteins with log2 .0.5 or ,20.5 fold expression changes are listed in Tables S3, S4, S5, S6.
doi:10.1371/journal.pgen.1002253.g005
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Replicative lifespan assays were carried out as described
previously [54]. Unless otherwise noted, all lifespan experiments
were performed on YPD plates with 2% glucose. Lifespan assays
under dietary restriction (DR) were performed on YPD with
0.05% glucose. Lifespan curves in Figure 1A–1D, Figure 4A, and
Figure 9A, 9B, 9E were compiled from multiple assays containing
experimentally matched WT and single mutant controls. The
strains used for Figure 1B were congenic.
Quantitative real-time PCR analysis
Strains were grown to mid-log phase (O.D. 600nm=0.5). Cell
extracts were prepared with glass bead lysis. Total RNA was
purified using a QIAGEN RNeasy kit according to the
manufacturer’s instructions. 1 mg RNA was reverse transcribed
using Bio-Rad’s iScript cDNA synthesis kit containing oligo(dT)
and random hexamer primers. Lysate preparation, RNA
purification and reverse transcription were performed on
multiple biological samples in parallel. cDNA products were
Figure 6. Correlation between resistance towards proteotoxic stress and proteasome abundance. Increased resistance to canavanine, ER
or oxidative stress upon UBR2 or MUB1 deletion. Serially diluted log phase cultures of WT, rpn4D, ubr2D, mub1D, rpn4D ubr2D and rpn4D mub1D
strains were spotted on (A) synthetic media in the presence (left panel) or absence (middle panel) of arginine, in the absence (left and middle panel)
or presence (right panel) of 3 mg/ml of the arginine analog canavanine, on (B) complete media in the absence (left panel) or presence of 0.5 mg/ml
tunicamycin (right panel) or on (C) complete media in the absence (left panel) or presence of 50 mM cadmium chloride (right panel).
doi:10.1371/journal.pgen.1002253.g006
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detection according to manufacturer’s recommendations. Primer
sequences are listed in Table S7. Serial dilutions of ubr2D cDNA
were used as standards. Six (Figure 4B) or nine (Figure 2B)
technical replicates were performed from each of three biological
samples for all strains and transcripts queried. The ratio of target
to PRP8 transcript signal was taken for experiment-matched
technical replicates and then averaged for each biological
sample. One-way ANOVA tests were performed between strain
transcript level averages to assess significance using GraphPad’s
Prism software.
Gel electrophoresis and immunoblotting
Anti-proteasome antibodies were obtained from BioMol (anti-
CP) or a kind gift of Daniel Finley (anti-Rpn5 and anti-Rpn8) and
anti-Pgk1 was from Invitrogen. Analysis of intact proteasome
species in unfractionated lysate was done as described previously
[55]. Briefly, post-diauxic shift cells were harvested, resuspended in
lysis buffer (50 mM Tris-HCl, pH 7.5, 0.5 mM EDTA, 5 mM
MgCl2, protease inhibitor cocktail tablet, Roche) and drop-frozen
in liquid nitrogen. Frozen yeast cells were lysed by cryolysis using
an MM301 grinding mill (Retsch, Germany) following the
manufacturer protocol. Cell extracts were cleared at 13,000 rpm
Figure 7. Cells with higher proteasome capacity exhibit increased turnover of unstable proteasome substrates in vivo. (A) The half-life
of the unstable GFP variant D2GFP was determined in post diauxic shift WT (upper panel, left), rpn4D (upper panel, right), ubr2D (lower panel, left)
and ubr2D rpn4D (lower panel, right) cells after blocking new synthesis with lethal doses of CHX, followed by immunodetection of the protein. anti-
Pgk1 was used as a loading control (lower panels). (B) Signals in (A) were detected using ECL chemiluminescence in an ImageQuant instrument and
quantified with the ImageQuantTL software. Control normalized values are presented.
doi:10.1371/journal.pgen.1002253.g007
Elevated Proteasome Capacity Extends Lifespan
PLoS Genetics | www.plosgenetics.org 11 September 2011 | Volume 7 | Issue 9 | e1002253Elevated Proteasome Capacity Extends Lifespan
PLoS Genetics | www.plosgenetics.org 12 September 2011 | Volume 7 | Issue 9 | e1002253Figure 8. Amelioration of Htt103Q aggregation in cells with higher proteasome capacity. Live cell fluorescence images of WT (A) or ubr2D
(B) cells expressing inducible Htt103Q-CFP or (C) Htt25Q-CFP were taken after 8 h (left panels) or 14 h of induction. 25Q overexpressing cells exhibit a
soluble CFP signal after 8 h and 14 h of induction in WT and UBR2 deleted cells. All fluorescent images were recorded under the same conditions and
represent merged Z-stacks. Corresponding transmitted light images (DIC) are shown below each fluorescent image.
doi:10.1371/journal.pgen.1002253.g008
Figure 9. Impact of proteasome capacity on longevity is largely unaffected by known lifespan mediating pathways. Mean lifespan
and cell counts are shown in parenthesis. (A) rpn4D induced lifespan shortening is partially rescued by tor1D or (B) by dietary restriction (DR). Survival
curves of rpn4D, tor1D and rpn4D tor1D or WT and rpn4D in the presence of 2% (A) or 0.05% glucose (B) (DR). (C) ubr2D and (D) mub1D mediated
lifespan extension is independent of GCN4. Survival curves of gcn4D, ubr2D, and ubr2D gcn4D or gcn4D, mub1D, and mub1D gcn4D cells. (E) ubr2D
mediated lifespan extension is independent of SIR2 and FOB1. Survival curves of sir2D fob1D, ubr2D, and ubr2D sir2D fob1D cells. A statistical analysis
of the data is summarized in Table S2.
doi:10.1371/journal.pgen.1002253.g009
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concentration was determined by a Bradford assay (BioRad) using
bovine serum albumin as standard. After clarification of the lysate
by centrifugation, protein content was assessed by a Bradford
assay. Equal amount of total protein (150 mg Figure 2C, left panel,
200 mg Figure 2C, right panel) were applied to native gels
composed of 3.5% acrylamide, 90 mM Tris-base, 90 mM boric
acid, 1 mM ATP, 5 mM MgCl2, 0.5 mM EDTA, which were run
in the same buffer omitting the acrylamide. The gels were run at
100V for 3 h at 10uC, incubated for 30 min at 30uC in substrate
buffer (50 mM Tris-HCl [pH 7.4], 5 mM MgCl2, 1 mM ATP,
0.05 mM Suc-LLVY-AMC (Bachem) for the in-gel activity assay
unless otherwise indicated. Active bands were visualized using an
UV screen at 340 nm. To assess equal loading the same samples
were subjected to SDS-PAGE followed by immunodetection with
anti-CP and anti-Pgk1 antibodies.
Proteasome activity assay
Post-diauxic shift cells were harvested, resuspended in lysis
buffer (50 mM Tris-HCl, pH 7.5, 0.5 mM EDTA, 5 mM MgCl2,
protease inhibitor cocktail tablet, Roche) and drop-frozen in liquid
nitrogen. Frozen yeast cells were lysed by cryolysis using an
MM301 grinding mill (Retsch, Germany) following the manufac-
turer protocol. Cell extracts were cleared at 13,000 rpm for
30 min at 4uC to remove insoluble material. Protein concentration
was determined by a Bradford assay (BioRad) using bovine serum
albumin as standard. Proteasomal chymotrypsin-like activity was
assessed using Suc-LLVY-AMC (Bachem), Boc-RLR-AMC (Ba-
chem) or Ac-nLPnL-AMC (Bachem). The assays were performed
in lysis buffer in a final reaction volume of 200 ml with 50 mg total
lysate protein in 96-well black microtitre plates (Costar) with
100 mM peptide substrate. The initial rate of fluorescence increase
was recorded after incubation for 15 min at 30uC with an
excitation wavelength of 380 nm and an emission wavelength of
460 nm in a SpectraMAX M5 multifunctional plate reader
(Molecular Devices). The initial rates of peptide hydrolysis were
determined in triplicates each in the presence and absence of the
proteasome inhibitor MG132 (50 mM, Calbiochem).
Growth curves
Cultures were inoculated for 36 h in YPD. Subsequently, 2.5 ml
aliquots were added to 147.5 ml YPD in a HC2 plate. Growth was
recorded in a Bioscreen C MB machine (Growth Curves USA) for
24 h at 30uC under continuous shaking and with 420–580 nm
absorbance readings every 30 minutes.
Selective reaction monitoring (SRM) of Rpn4 expression
in total cell lysate
Yeast cells were grown in YPD to O.D.600nm 3. RPN4
expression was induced by addition of 50 mM CdCl2 for 1 h at
30uC. Protein extracts were prepared using glass bead lysis in a
buffer containing 6 M Urea/2 M ThioUrea/20 mM HEPES,
pH 7.2. Peptides were generated using a two-step digest as
described in deGodoy et al. [56] and separated on a 15 cm reverse
phase column (3 mM Reprosil, Dr. Maisch, packed in house) using
a 10 to 50% acetonitrile gradient. Peptides were sprayed directly
into the mass spectrometer (4000 Q-TRAP, ABSciex) and ionized
using a NanoII ion source (ABSciex). Data were recorded using
the selected reaction-monitoring mode (SRM/MRM) of the
instrument analyzed using the MultiQuant 1.3 (ABSciex) and R
software packages (www.R-project.org) [57]. The different runs
were normalized to the trace of the y12 fragment ion of an actin
peptide (SYELPDGQVITIGNER).
SILAC (stable isotope labeling in cell culture)–based
proteomic comparison of rpn4D and ubr2Dcells
Yeast strains (WT, rpn4D, ubr2D) were grown in complete
minimal media supplemented with isotopically labeled lysine to
O.D. 600nm 3. 50 mM CdCl2 was added and the cells were grown
for an additional hour. Wild type cells were labeled with light
(lysine 0), rpn4D cells with medium (lysine 4) and ubr2D cells with
heavy lysine (lysine 8). Equal amounts of cells were mixed,
resuspended in 1x SDS sample buffer and lysed using glass beads.
After centrifugation the clear supernatant was concentrated in a
Milipore Amicon ultra cartridge (10 kD cut-off). Proteins were
separated on a 12% SDS-PAGE. The gel was cut in 12 slices and
each slice was subjected to an in-gel digest using Endopeptidase
LysC (Wako Chemicals) [56]. The recovered peptides were
separated on a 15 cm reverse phase column (in house packed,
3 mm ReproSil-Pur C18, Dr. Maisch) and sprayed directly into the
LTQ-OrbiTRAP mass spectrometer (Thermo). The recorded data
were analyzed using the MaxQuant [58] and R software package
(www.R-project.org).
Phenotypic analysis of gene deletions
Overnight cultures were diluted to O.D. 660nm 0.1, incubated
for 4 h at 30uC to obtain exponentially growing cultures. The
cultures were diluted in 96 well plates with YPD to a density of
6610
6 cells per well, followed by 5-fold serial dilutions and spotted
onto YPD plates in the absence or presence of 0.5 mg/ml
tunicamycin (Sigma Aldrich), 50 mM cadmium chloride (Sigma
Aldrich) or onto synthetic arginine drop out plates in the absence
or presence of 3 mg/ml canavanine (Sigma Aldrich).
Turnover of the unstable proteasome model substrate
D2GFP
Overnight cultures of cells constitutively expressing D2GFP-HA
were diluted to O.D. 660nm 0.5 and incubated for 2 h in synthetic
media. New synthesis was blocked by the addition of 200 mg/ml
CHX. At the time indicated aliquots were harvested and frozen in
liquid nitrogen. After alkaline lysis [59] and measuring the total
protein concentration with a Bradford reagent (Pierce), 20 mg were
subjected to SDS-PAGE and immuno-detection using an anti-
GFP polyclonal antibody (Clontech). Signals were visualized using
ECL chemiluminescence in an ImageQuant LAS 4000 imager
(GE Healthcare) and quantified using the ImageQuant software
package.
Visualization of PolyQ extended Huntingtin exon1
aggregation via live cell fluorescence microscopy
Cells were grown at 30uC on solid selective synthetic complete
medium with 2% glucose. For induction of 25Q or 103Q, cells
were transferred into liquid selective synthetic complete medium
with 2% raffinose, induced by addition of 2% galactose and grown
for the times indicated. For imaging, 1 O.D. 600nm of cells were
transferred to ConA coated 35 mm imaging dishes, washed 3x and
mounted to the microscope. CFP fluorescence images were taken
using the Olympus BX81 microscope equipped with a 150x
objective, a narrow band CFP filter and an Andor iXon8
EMCCD for data acquisition. All images were taken under the
same conditions with 20–31 serial Z-sections (0.2 mm/section and
0.2 s exposure/section) to cover the thickness of the cells. For data
acquisition the Andor imaging software IQ 2.2 were used. Z-stacks
were merged with ImageJ 1.37v.
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Figure S1 Pairwise p-value comparison of the qRT-PCR data
presented in Figure 2B. Statistical significance was assessed by a
one-way Anova analysis using the GraphPad Prism software.
(TIF)
Figure S2 Proteasomal peptidase activity in unfractionated
lysates in the presence of the proteasome inhibitor MG132. The
same samples as in Figure 3A were subjected to an analysis of the
three distinct proteasomal activities in the presence of the
proteasome-specific inhibitor MG132. The same scale is used as
in Figure 3A. Note: MG132 only weakly affects the trypsin-like
activity of the proteasome.
(TIF)
Figure S3 Average strain generation time calculated from the
growth curves presented in Figure 3B.
(TIF)
Table S1 Strains used in this study.
(PDF)
Table S2 Statistical analysis of the RLS experiments presented.
Curve comparisons were assessed by a Wilcoxon test. Rank sum p-
values: * p , 0.05, ** p , 0.01, *** p , 0.001, ns = not
significant.
(PDF)
Table S3 Proteins upregulated in rpn4D cells with a log2(ratio) .
0.5 relative to WT abundance after cadmium chloride treatment.
(PDF)
Table S4 Proteins downregulated in rpn4D cells with a log2
(ratio) ,20.5 relative to WT abundance chloride treatment.
(PDF)
Table S5 Proteins upregulated in ubr2D cells with a log2(ratio) .
0.5 relative to WT abundance chloride treatment.
(PDF)
Table S6 Proteins downregulated in ubr2D cells with a log2
(ratio) ,20.5 relative to WT abundance chloride treatment.
(PDF)
Table S7 Primer Sequences. This table lists the primer
sequences used for qRT-PCR experiments.
(PDF)
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